Aquestive Therapeutics, Inc.: adopts amended bylaws

What happened Aquestive Therapeutics, Inc. reported on Oct 19, 2026 that on Oct 15, 2026 its Board of Directors "approved and adopted amended and restated bylaws" (the Amended Bylaws), effective Oct 15, 2026. The Amended Bylaws supersede the company's prior amended and restated bylaws.

Key details

• The Amended Bylaws amend Article I, Section 11, which sets requirements for stockholder nominations of candidates for election to the Board.
• The amended language eliminates the requirement that a proposing stockholder provide information concerning certain relationships between the nominating stockholder and any "Stockholder Associated Person" and "others acting in concert with" the proposed nominee, members of the nominee’s immediate family, and the nominee’s affiliates and associates.
• The definition of "Stockholder Associated Person" was revised to remove persons "acting in concert with" nominating stockholders or beneficial owners on whose behalf nominations or proposals are brought.
• The filing states that certain technical, conforming and non-substantive changes were also made.

Why it may matter This report was made under Item 5.03 (Amendments to articles of incorporation or bylaws), which covers changes to the company's bylaws. A filing does not show why the insider traded or why the company acted.